All News

2067 articles, sorted by publication time.

Precision Medicine · us

From Understanding Tumors to Influencing Treatment: 10x Genomics Plans Clinical Laboratory, Starting with Bladder Cancer

Single-cell and spatial biology have long excelled at mapping tumors, but they do not necessarily provide a direct answer to which drug a patient should receive. Through a CLIA laboratory expected to begin operations in 2027 and collaborations with hospitals, 10x Genomics is attempting to bridge the gap between research tools and clinical testing.

Clinical Trials · us

Limited Options After CNS Lymphoma Relapse, Dual-Pathway Blockade Shows Early Efficacy Signal

Curis has updated early trial results for emavusertib combined with ibrutinib: responses were more concentrated among patients with no prior BTK inhibitor use, while some tumor shrinkage was also seen in previously treated patients; however, the small patient numbers and differing cohort designs are not yet sufficient to confirm the magnitude of efficacy.

Microbiology · us

Drug Resistance Does Not Always Emerge Gradually: Bacteria in the Lungs “Borrow Genes,” Making Pseudomonas aeruginosa Stronger in an Instant

Pathogens in the lungs of people with cystic fibrosis may not need to wait for a series of mutations. Simply receiving plasmids brought in by foreign bacteria can cause antibiotic resistance to surge by thousands or even more than ten thousand times. This study of human specimens rewrites the timescale on which drug resistance develops during infection.

Clinical Trials · global

Triple-Hormone Drug Clears Two Phase 3 Trials, With Striking Weight Loss but Uncertain Cardiovascular Benefit

Retatrutide produced average weight loss of more than 20% in two high-risk populations—people with diabetes and those with established cardiovascular disease—giving Lilly the core clinical data needed for planned global submissions; however, an insufficient number of events means whether it can truly reduce cardiovascular risk remains inconclusive.